Bullfrog AI Holdings SG&A Expenses 2022-2024 | BFRG
Bullfrog AI Holdings sg&a expenses from 2022 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Bullfrog AI Holdings Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $4 |
| 2022 | $2 |
| 2021 | $1 |
| Bullfrog AI Holdings Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $1 |
| 2023-12-31 | $1 |
| 2023-09-30 | $1 |
| 2023-06-30 | $1 |
| 2023-03-31 | $1 |
| 2022-12-31 | $0 |
| 2022-09-30 | $1 |
| 2022-06-30 | $1 |
| 2022-03-31 | $0 |
| 2021-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.022B | $0.000B |
| BullFrog AI Holdings Inc. is a digital biopharmaceutical company which focuses on artificial intelligence and machine learning driven analysis of data sets in medicine and healthcare principally in the United States. BullFrog AI Holdings Inc. is based in Gaithersburg, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.864B | 19.69 |
| Inspire Medical Systems (INSP) | United States | $4.586B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.375B | 0.00 |
| Axonics (AXNX) | United States | $3.425B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.985B | 0.00 |
| Azenta (AZTA) | United States | $2.746B | 154.39 |
| IRhythm Technologies (IRTC) | United States | $2.741B | 0.00 |
| Enovis (ENOV) | United States | $2.730B | 20.24 |
| 10x Genomics (TXG) | United States | $2.671B | 0.00 |
| Privia Health (PRVA) | United States | $2.059B | 115.07 |
| Schrodinger (SDGR) | United States | $1.583B | 0.00 |
| Omnicell (OMCL) | United States | $1.499B | 51.83 |
| Phreesia (PHR) | United States | $1.221B | 0.00 |
| Standard BioTools (LAB) | United States | $0.947B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.639B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.625B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.455B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.384B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.331B | 0.00 |
| Pulmonx (LUNG) | United States | $0.283B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.211B | 0.00 |
| Outset Medical (OM) | United States | $0.183B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.154B | 0.00 |
| TruBridge (TBRG) | United States | $0.139B | 7.49 |
| American Well (AMWL) | United States | $0.119B | 0.00 |
| 111 (YI) | China | $0.105B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.096B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.074B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.060B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.049B | 0.00 |
| Augmedix (AUGX) | United States | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Zepp Health (ZEPP) | China | $0.044B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.025B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Cue Health (HLTH) | United States | $0.012B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |